抗糖尿病药物和2型糖尿病的膀癌风险:随机对照试验的系统审查和元分析
Yufeng Rao1, Shiqiu Meng2, Evan Yi-Wen Yu3
1Department of Epidemiology, Maastricht University, Maastricht, the Netherlands; Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
概括
这项研究发现,常见的抗糖尿病药物与2型糖尿病 (T2DM) 患者的膀癌 (BC) 风险之间没有显著联系. 这些发现支持这些必不可少的T2DM治疗的长期安全性.
科学领域:
- 内分泌学和新陈代谢学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗糖尿病药物的长期安全性对于管理2型糖尿病 (T2DM) 至关重要.
- 抗糖尿病药物与膀癌 (BC) 风险之间的潜在关联需要彻底调查.
研究的目的:
- 系统地审查和元分析随机对照试验 (RCT),评估抗糖尿病药物与膀癌 (BC) 风险之间的关联.
- 在T2DM患者中评估各种抗糖尿病药物类别的安全性,以评估BC发生率.
主要方法:
- 在T2DM患者中,对RCT进行系统审查和元分析,将抗糖尿病药物与安慰剂进行比较.
- 搜索的主要数据库 (PubMed,Embase,科学网,Cochrane) 截至2025年6月.
- 使用随机效应模型对合并的几率比率 (OR) 和95%置信区间 (CI);通过漏斗图表评估I2统计和出版偏差的异质性.
主要成果:
- 总的来说,抗糖尿病药物与增加或减少BC风险没有显著的关联 (OR = 0.90,95%CI:0.67-1.20).
- 对DPP-4抑制剂,GLP-1受体激动剂和SGLT-2抑制剂的亚组分析也显示没有统计学上显著的BC风险.
- 在一项研究中, thiazolidinediones 显示OR (2.37) 的非显著增加;没有发现显著的出版偏差.
结论:
- 目前的证据表明,常用的抗糖尿病药物,包括DPP-4i,GLP-1Ras和SGLT-2i,不会显著增加T2DM患者的膀癌风险.
- 这些发现加强了这些抗糖尿病药物类别在T2DM管理中的长期安全性.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
562
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
562
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Dipeptidyl Peptidase 4 Inhibitors
557
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
557
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
505
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
505
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K


